Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Chapman, Arlene

One or more keywords matched the following items that are connected to Chapman, Arlene

Item Type	Name
Concept	Glomerular Filtration Rate
Academic Article	Acute Response to Tolvaptan in ADPKD: A Window to Predict Long-term Efficacy?
Academic Article	Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC).
Academic Article	Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.
Academic Article	Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.
Academic Article	Blood pressure in early autosomal dominant polycystic kidney disease.
Academic Article	Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
Academic Article	Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.
Academic Article	Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Academic Article	Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis.
Academic Article	Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort.
Academic Article	Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
Academic Article	Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.
Academic Article	Volume progression in polycystic kidney disease.
Academic Article	Angiotensin blockade in late autosomal dominant polycystic kidney disease.
Academic Article	Analysis of baseline parameters in the HALT polycystic kidney disease trials.
Academic Article	Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
Academic Article	Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial.
Academic Article	Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.
Academic Article	Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.
Academic Article	Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease.
Academic Article	Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial.
Academic Article	Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease.
Academic Article	Urine peptidome analysis predicts risk of end-stage renal disease and reveals proteolytic pathways involved in autosomal dominant polycystic kidney disease progression.
Academic Article	Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.
Academic Article	Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
Academic Article	Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
Academic Article	Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.
Academic Article	Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.
Academic Article	Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.
Academic Article	Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial.
Academic Article	Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
Academic Article	Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
Academic Article	A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan.
Academic Article	Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
Academic Article	Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort.
Academic Article	Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease.
Academic Article	Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.
Academic Article	Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease.
Academic Article	The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.
Academic Article	Mineral bone disease in autosomal dominant polycystic kidney disease.
Academic Article	Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease.
Academic Article	Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions.
Academic Article	Utilization of Cystatin C in the Outpatient Setting.
Academic Article	Effects of Bardoxolone Methyl in Alport Syndrome.
Academic Article	Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial.
Academic Article	Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation.
Academic Article	ALTERATIONS IN HISTIDINE METABOLISM IS A FEATURE OF EARLY AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD).

Search Criteria

Filtration